As the use of telehealth and tele-mental health services continued to grow during the COVID-19 pandemic, disparities in access and usage also were exposed. Read on to learn more about the role of telehealth in supporting health equity.

To mark Pride Month, we talk with cancer survivor and patient advocate Tony Burns. In this Q&A, we learn about the native Washingtonian’s personal experience with cancer. Tony also talks with us about health inequities in the LGBTQ community and shares ways we can work to overcome them.

The Cancer Support Community has added 3 new educational resources to the Frankly Speaking About Cancer: Clinical Trials library. The materials highlight the importance of diversity in clinical trials and provide information for patients to determine if a clinical trial is right for them.

Over one year since COVID-19 was first declared a public health emergency, the pandemic continues to pose increased risks and burdens on cancer patients and survivors and has illuminated the longstanding disparities in our health care system. Read on to learn more about what can be done to improve health equity in the COVID-19 response.

The Cancer Support Community is committed to supporting efforts that advance health equity for all. In recognition of National Minority Health Month, we share 6 ways we are working to conquer language barriers in cancer care.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in health advocacy. This month, for National Minority Health Month, we are spotlighting health equity in cancer care. Read on to learn more about this important topic from Eucharia Borden, CSC’s Senior Director of Health Equity and Clinical Services.

The Henrietta Lacks Enhancing Cancer Research Act seeks to reduce barriers and increase access to participation in government-funded cancer clinical trials among communities that are traditionally underrepresented in trials. Read more about this important law and the legacy of Henrietta Lacks.

Since the signing of the National Cancer Act in 1971, scientific and medical progress has resulted in extraordinary advancements in our ability to treat cancer. However, equally as important as treatment advances is our ability to detect cancer at the earliest stages, when the chance of surviving for at least 5 years is high.

When health care providers investigate cancer diagnoses and cancer survival rates, it is important for them to examine the disparities between various demographics and what causes these differences as they may impact treatment decision making and outcomes.